Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

N Gianotti; A Cozzi Lepri; A Antinori; A Di Biagio; Mc Moioli; S Nozza; Antonella Cingolani; Andrea De Luca; G Madeddu; S Bonora; F Ceccherini Silberstein; Ad Monforte

doi:10.7448/IAS.17.4.19799

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

N Gianotti, A Cozzi Lepri, A Antinori, A Di Biagio, Mc Moioli, S Nozza, Antonella Cingolani, Andrea De Luca, G Madeddu, S Bonora, F Ceccherini Silberstein, Ad Monforte

Risultato della ricerca: Contributo in libro › Contributo a convegno

Abstract

We aimed at evaluating the efficacy and durability of a lopinavir/ritonavir-based dual regimen (LPV/r-DR) in virologically controlled HIV-infected individuals in current clinical practice.

Lingua originale	English
Titolo della pubblicazione ospite	Journal of International AIDS Society.
Pagine	19799
Numero di pagine	1
DOI	https://doi.org/10.7448/IAS.17.4.19799
Stato di pubblicazione	Pubblicato - 2014
Evento	Drug Therapy Glasgow Congress 2014 - Glasgow Durata: 2 nov 2014 → 6 nov 2014

Convegno

Convegno	Drug Therapy Glasgow Congress 2014
Città	Glasgow
Periodo	2/11/14 → 6/11/14

Keywords

HIV
dual therapy

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.7448/IAS.17.4.19799

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Gianotti, N., Cozzi Lepri, A., Antinori, A., Di Biagio, A., Moioli, M., Nozza, S., Cingolani, A., De Luca, A., Madeddu, G., Bonora, S., Ceccherini Silberstein, F., & Monforte, A. (2014). Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting. In Journal of International AIDS Society. (pagg. 19799) https://doi.org/10.7448/IAS.17.4.19799

@inproceedings{9e2f98b7c9c3422399126d53c967c9b0,

title = "Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting",

abstract = "We aimed at evaluating the efficacy and durability of a lopinavir/ritonavir-based dual regimen (LPV/r-DR) in virologically controlled HIV-infected individuals in current clinical practice.",

keywords = "HIV, dual therapy, HIV, dual therapy",

author = "N Gianotti and {Cozzi Lepri}, A and A Antinori and {Di Biagio}, A and Mc Moioli and S Nozza and Antonella Cingolani and {De Luca}, Andrea and G Madeddu and S Bonora and {Ceccherini Silberstein}, F and Ad Monforte",

year = "2014",

doi = "10.7448/IAS.17.4.19799",

language = "English",

isbn = "1758-2652",

pages = "19799",

booktitle = "Journal of International AIDS Society.",

note = "Drug Therapy Glasgow Congress 2014 ; Conference date: 02-11-2014 Through 06-11-2014",

}

Gianotti, N, Cozzi Lepri, A, Antinori, A, Di Biagio, A, Moioli, M, Nozza, S, Cingolani, A, De Luca, A, Madeddu, G, Bonora, S, Ceccherini Silberstein, F & Monforte, A 2014, Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting. in Journal of International AIDS Society.. pagg. 19799, Drug Therapy Glasgow Congress 2014, Glasgow, 2/11/14. https://doi.org/10.7448/IAS.17.4.19799

TY - GEN

T1 - Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

AU - Gianotti, N

AU - Cozzi Lepri, A

AU - Antinori, A

AU - Di Biagio, A

AU - Moioli, Mc

AU - Nozza, S

AU - Cingolani, Antonella

AU - De Luca, Andrea

AU - Madeddu, G

AU - Bonora, S

AU - Ceccherini Silberstein, F

AU - Monforte, Ad

PY - 2014

Y1 - 2014

N2 - We aimed at evaluating the efficacy and durability of a lopinavir/ritonavir-based dual regimen (LPV/r-DR) in virologically controlled HIV-infected individuals in current clinical practice.

AB - We aimed at evaluating the efficacy and durability of a lopinavir/ritonavir-based dual regimen (LPV/r-DR) in virologically controlled HIV-infected individuals in current clinical practice.

KW - HIV

KW - dual therapy

KW - HIV

KW - dual therapy

UR - http://hdl.handle.net/10807/63933

U2 - 10.7448/IAS.17.4.19799

DO - 10.7448/IAS.17.4.19799

M3 - Conference contribution

SN - 1758-2652

SP - 19799

BT - Journal of International AIDS Society.

T2 - Drug Therapy Glasgow Congress 2014

Y2 - 2 November 2014 through 6 November 2014

ER -

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

Abstract

Convegno

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo